The Legacy Effect in the Prevention of Cardiovascular Disease

Esther Viñas Esmel1, José Naval Álvarez1, Emilio Sacanella Meseguer1,2

  • 1Department of Internal Medicine, Hospital Clínic, Institut d'Investigació Biomèdica August Pi i Sunyer (IDIBAPS), University of Barcelona, Villarroel 170, 08036 Barcelona, Spain.

Nutrients
|October 27, 2020
PubMed

Insights

The cardiovascular disease (CVD) legacy effect shows long-term benefits after intensive risk factor treatment. This effect varies by risk factor, patient, and intervention, being more pronounced in those with moderately high risk and recent diabetes.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Metabolic Disorders

Background:

  • The legacy effect, or long-term benefits post-intervention, is recognized in various biological processes.
  • Limited research exists on the legacy effect in cardiovascular disease (CVD) prevention, particularly concerning dietary interventions.
  • Most studies focus on intensive pharmacological interventions targeting cardiovascular risk factors.

Purpose of the Study:

  • To review and synthesize findings on the legacy effect in CVD prevention.
  • To assess the existence and characteristics of the legacy effect in cardiovascular health.
  • To identify factors influencing the legacy effect in different patient populations.

Main Methods:

  • Systematic review of existing literature on cardiovascular disease prevention interventions.
  • Analysis of studies reporting long-term outcomes after the cessation of intensive treatment regimens.
  • Evaluation of data regarding the impact of patient characteristics and intervention types on the legacy effect.

Main Results:

  • Sufficient evidence supports a legacy effect following intensive intervention on cardiovascular risk factors.
  • The legacy effect is not uniform across all risk factors and is influenced by patient specifics, disease duration, and intervention type.
  • The effect appears greater in individuals with moderately high cardiovascular risk but no established CVD, especially those with recent-onset diabetes.

Conclusions:

  • A discernible legacy effect exists in cardiovascular risk factor management, though its magnitude varies.
  • The legacy effect is more pronounced in specific subgroups, such as patients with recent-onset diabetes and moderately high cardiovascular risk.
  • Discontinuation of preventive CVD treatment is not advised in high-risk individuals due to limited evidence on the legacy effect's reliability in this group.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
500
Lifestyle Factors and Health01:20

Lifestyle Factors and Health

Lifestyle factors play a critical role in maintaining overall health and preventing chronic diseases. Key elements, such as regular physical activity, a nutritious diet, and abstinence from smoking, can significantly enhance physical, mental, and emotional well-being while reducing the risk of several life-threatening conditions.
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
319
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
704
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
215
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
230
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
3.6K